Calcium, phosphorus, vitamin D, dairy products and colorectal carcinogenesis: a French case--control study. by Boutron, M. C. et al.
Britsh Journal of Cancer (1996) 74, 145-151
© 1996 Stockton Press All rights reserved 0007-0920/96 $12.00
Calcium, phosphorus, vitamin D, dairy products and colorectal
carcinogenesis: a French case-control study
M-C Boutron' 2, J Faivrel, P Marteau2, C Couillault1, P Senessel and V Quipourt'
'Registre Bourguignon des Cancers Digestifs, Faculte de Medecine, 21000 Dijon, France; 2Inserm U290, Hopital Saint Lazare, 107
rue du Faubourg Saint-Denis, 75010 Paris, France.
Summary A protective effect of calcium against colorectal cancer has been described in Anglo-Saxon but not
in Latin communities, and no such effect has been observed regarding adenomas. We investigated the
relationship between calcium, dairy products and the adenoma-carcinoma sequence in a French region by
comparing small adenoma (< 10 mm, n= 154), large adenoma (n=208) and polyp-free (n=426) subjects, and
cancer cases (n = 171) with population controls (n= 309). There was no protective effect of calcium against
colorectal tumours except for low fat calcium and large adenomas in men (OR for highest quintile=0.3, P for
trend =0.06). There was even a trend towards an increased risk of cancer with dairy calcium in men and non-
dairy calcium in women. Vitamin D was inversely related to the risk of small adenomas in women (OR for
highest quintile =0.4, P for trend=0.04). Regarding dairy products, only consumption ofyoghurt displayed an
inverse relationship with risk of large adenomas, in both men and women. These data failed to demonstrate a
protective effect ofcalcium against colorectal carcinogenesis. They suggest that the type ofdairy product might
be the important factor with regard to prevention of colorectal tumours.
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Several case-control and cohort studies have observed an
inverse association between colorectal cancer risk and
calcium intake (Bostick et al., 1993). However, data are not
consistent even within North America (Wu et al., 1987;
Willett et al., 1990). Most studies in Latin countries have not
observed such an effect and have even noted a positive
association between calcium and colorectal cancer (Benito et
al., 1991; Tuyns et al., 1988; Negri et al., 1990). Dairy
products have also been studied not only because they are the
main source of dietary calcium, but also because other
components may be ofinterest, such as the lactose content or
the bacteria in fermented dairy products. To date, no
significant association has been described between calcium
intake and colorectal adenomas (Kampman et al., 1994a).
This finding is all the more important since certain of the
current intervention studies with calcium supplements use
adenoma recurrence as an end point.
France has a tradition of high calcium intake, mainly in
the form of cheese. In order to define further the effect of
calcium, phosphate, vitamin D and dairy product intake on
the adenoma-carcinoma sequence, we carried out a case-
control study in a French community of the relationship
between these nutrients, as well as calcium-containing foods
and the different macroscopic steps of colorectal carcinogen-
esis, namely small adenoma, large adenoma and cancer.
Materials and methods
Cases and controls
A case-control study was set up between 1985 and 1990 to
investigate risk factors for the different macroscopic steps of
the adenoma-carcinoma sequence. Its general design has
already been described (Boutron et al., 1995). It consisted of
two parallel case-control studies, one examining risk factors
for colorectal adenomas, the other for colorectal cancer.
Cases and controls were residents aged 30 to 75 of the C6te
d'Or area (Burgundy, France). Exclusion criteria were
familial polyposis coli or hereditary non-polyposis colorectal
cancer and a previous history of colorectal tumour, inflam-
matory bowel disease, colectomy or any type of cancer.
Sample size calculations were based on fat intake, one of the
suspected major risk factors for colorectal cancer. Consider-
ing the proportion of the population exposed to a high-fat
diet, with a power of 80% to demonstrate a relative risk of
2.0 at the 5% level of significance, it was calculated that at
least 140 cases and 280 controls were needed in each group.
Two groups of patients with adenomas and polyp-free
controls were selected from the endoscopy lists of all
gastroenterologists in the area, whether in private or public
practice. Adenomas were subdivided by size: patients with
only small adenomas constituted the small adenoma group
(85 men and 69 women), patients with at least one adenoma
over 10 mm in diameter represented the large adenoma group
(129 men and 79 women), whereas subjects without any
polyp, either adenomatous or hyperplastic (182 men and 245
women), constituted the polyp-free group. The World Health
Organization classification of histological types of polyps
(Morson and Sobin, 1976) was used in both laboratories
which perform all pathological examinations in the area, and
using a consensus about classification achieved in a previous
study on adenomas. For the large and small polyp groups
and for the polyp-free control group, colonoscopy had to
reach at least the sigmoid to descending colonjunction and in
most cases, when incomplete, was completed by a double
contrast barium enema. Colonoscopy reached at least the
hepatic flexure in respectively 64.4%, 66.2% and 60.8% of
the cases. In the polyp groups, patients with hyperplastic
polyps only were excluded from the study.
Cancer cases (109 men and 62 women) were recruited
through all specialists in charge of such patients, with the
help of the Registry of Digestive Tumours of Burgundy. The
control group 'Population controls' (159 men and 150
women), were a random sample of the area in the relevant
age group obtained from the census list through the INSEE
(National Institute for Statistics and Economical Studies).
The mean age was similar in the two polyp groups
(61.6+ 10.2 for large and 59.5+ 11.2 for small adenomas), but
lower in the polyp-free group (54.1+14.0; P<0.01). The
mean age for cancer cases was 64.2+10.3, whereas it was
62.1 + 11.6 in population controls (P=0.05). Refusal rates
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were higher among population controls (46.5%) than in the
other groups; 20.1% for the cancer group, 14.0% for the
large polyp group, 20.2% for the small polyp group and
22.0% for the polyp-free controls.
Data
The diet history method which was used in this study had
been previously validated (Boutron et al., 1989). It was a
detailed 2 h questionnaire about the diet in the past year
which followed the pattern of meals throughout the day. It
was administered at the subjects' homes by a specially trained
dietician who also coded the data. A food composition table
that used data from available food composition tables and
additional information from the food industry had been
established for the purpose of the study. It included in
particular a detailed list of dairy products. The following
broad groups were used: (1) milk (total), subdivided into (2)
skim or low-fat milk, (3) full-fat milk, (4) hard and semihard
cheese, (5) cottage cheese and (6) yoghurt. The latter is
defined in France as a fermented milk containing living
Lactobacillus delbrueckii subsp. bulgaricus and Streptococcus
salivarius subsp. thermophilus. All nutritional data were
transformed into a mean daily intake of nutrients. Dietary
calcium intake was studied as total calcium, non-dairy
calcium, dairy calcium, high-fat dairy calcium (over 20 g fat
per g calcium) and low-fat dairy calcium. We also studied
dietary vitamin D and phosphorus intakes as well as the
calcium-phosphorus ratio.
Categories
For nutrients and widely consumed food items, categories
were determined separately by sex, from the distribution into
quintiles of each control group, the polyp-free group for the
adenoma groups, the population-based controls for the
cancer group. For food items which were rarely consumed,
two or three groups were established. For full-fat milk,
consumers were compared with non-consumers. For cottage
cheese and yoghurt, three groups consisted of: no consump-
tion, low and high consumption, the cut-off point between
the last two groups being the median intake in consumers. In
the male population controls, proportions of non-consumers
were 48.4% for cottage cheese, 49.7% for yoghurt and 52.8%
for full-fat milk. In the male polyp-free controls, correspond-
ing proportions were 52.2%, 36.8% and 49.5%. In women,
non-consumers among population controls were 36.7% for
cottage cheese, 29.3% for yoghurt and 46.7% for full-fat
milk. Similarly in polyp-free controls, they were 38.4%,
24.1% and 46.1%. Cut-off points for the categories are listed
in Table I.
Analysis
In order to follow the general scheme of the adenoma-
carcinoma sequence, the small adenoma group was compared
with the polyp-free controls, the large adenoma group with
the small adenoma group, the cancer group with the
population control group. Analyses were performed using
comparison of mean daily intakes, after logarithmic
transformation for equality of variance and multiple logistic
regression controlling for age, sex and caloric intake. Odds
ratios for estimating the relative risk for different levels of
consumption were calculated using as a reference the
category of no or lowest consumption. The statistical
significance of each studied variable was tested by the
maximum likelihood method.
Results
Calcium, phosphorus, vitamin D and colorectal adenomas
Mean intake of calcium (±standard deviation) was slightly
higher in polyp-free controls compared with small or large
adenoma patients in both men and women. In men, it was
1349+533 mg day-' in polyp-free controls, 1221 +435
mg day-' in small adenoma patients (P= 0.09) and
1229+433 mg day-' in large adenoma patients. Values were
lower in women, with corresponding figures of 1142+
427mg day-', 1073+385mg day-' and 1080+422mg
day-'. Relative risks of small or large adenomas according
to the intake of selected nutrients, controlling for age and
caloric intake are presented in Table II. There was no
significant effect of calcium, whatever its source, on the risk
Table I Cut-off points for the categories of the main studied nutrients and dairy products (quintiles except for yoghurt) among the polyp-free
controls and the population controls
Cut-offpoints
Food item Sex 1 2 3 4
Polyp-free controls
Phosphorus (mg day-1) Men 1241.9 1557.4 1734.6 2038.7
Women 1003.4 1180.9 1337.6 1554.3
Calcium (mg day-') Men 890.0 1166.0 1378.6 1712.5
Women 806.9 984.7 1156.1 1413.0
Vitamin D (pg day-1) Men 3.0 3.9 5.0 5.3
Women 2.4 3.2 4.0 6.4
Milk (g day-l) Men 14.2 60.6 149.9 270.4
Women 18.0 46.3 98.9 230.9
Cheese (g day-1) Men 34.0 52.6 71.5 95.8
Women 25.2 43.3 62.4 85.1
Yoghurt (g day-1) Men 0 62.9
Women 0 71.4
Population controls
Phosphorus (mg day-1) Men 1127.7 1327.5 1480.8 1743.9
Women 900.7 1032.7 1203.8 1393.9
Calcium (mg day-l) Men 766.4 904.8 1060.6 1287.0
Women 722.6 873.3 1033.9 1214.5
Vitamin D (Mg day-l) Men 2.5 3.4 4.3 5.7
Women 2.1 2.5 3.3 4.7
Milk (g day-l) Men 14.2 62.7 147.9 459.4
Women 20.0 76.3 157.8 262.6
Cheese (g day-l) Men 34.0 52.6 71.5 95.8
Women 17.6 40.0 59.4 84.3
Yoghurt (g day-') Men 0 26.3
Women 0 69.8Calcium, dairy products and colorectal tumours
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of small or large adenomas. Results were similar when
considering men and women separately: the odds ratio for the
highest quintile of intake compared with the lowest was 0.8
(0.3-2.2) in men and 1.0 (0.4-2.4) in women for small
adenomas and 0.8 (0.3-2.4) in men and 1.0 (0.3-3.5) in
women for large adenomas. Regarding the type of calcium
intake, only non-dairy calcium tended to be associated with a
reduced risk of small adenomas in both sexes (OR for the
highest quintile 0.6; 0.3-1.1). Regarding large adenomas,
there was a suggestion that low-fat calcium might be
protective in men (OR highest vs lowest quintile, 0.3; 0.1-
1.0; P=0.06), but not in women (OR, 0.8; 0.2-2.5; P=0.73).
High dietary intake of phosphorus or a low calcium to
phosphorus ratio were not associated with an increased risk
of adenomas whatever their size. The highest quintile for that
ratio was over 0.9 in men and 1.0 in women, whereas the
lowest was below 0.6 in men and 0.7 in women. This yielded
a relative risk of 0.9 for both small and large adenomas in
men, and 1.3 and 1.4 for small and for large adenomas
respectively in women. The highest quintile of phosphorus
intake was associated with a reduced risk of small adenomas
(OR=0.5; P for trend=0.06).
A high level ofvitamin D intake was inversely related to the
risk of small adenomas only in women, with a dose -effect
relationship and an odds ratio of 0.4 for the highest level of
intake, Pfor trend =0.04. There was no such association in men
where the corresponding figure was 1.2, P for trend =0.78 for
intake levels close to those in women. These results were not
modified when controlling for calcium intake and interaction
factors between calcium and vitamin D intakes were not
significant (P= 1.0 for small and 0.6 for large adenomas).
As some dairy products have a high fat content, we tested
whether fat intake acted as a confounder by including fat in
the logistic model. This modified neither the direction nor the
statistical significance of any of the relative risks calculated
with the calorie-adjusted model.
Calcium, phosphorus, vitamin D and colorectal cancer. (Table
III)
Mean consumptions of calcium were slightly higher in cases
than in controls, the difference being on the verge of
statistical significance in women after logarithmic transforma-
tion of the values. Mean consumptions were 1047+
338 mg day-' and 1134+435 mg day-' in male con-trols
and cancer patients respectively. In women, correspond-
ing figures were 1142+619 mg day-' and 1000+368 mg
day- '.
There was no significant protective effect of calcium intake
on the risk of colorectal cancer, with an odds ratio of 1.9
(0.8-4.7) in men and 1.5 (0.5-4.5) in women for the highest
vs lowest quintile of intake. Dairy calcium in men and non-
dairy calcium in women were even associated with an
increased risk of cancer, with figures of 2.7 (1.1-6.3; P for
trend 0.06) and 2.4 (0.9-6.6; P for trend 0.04) respectively
for the highest level of intake.
There was no significant association between vitamin D
intake and the risk of colorectal cancer and there was no
interaction between calcium and vitamin D intakes, P for
interaction =0.42. There was a trend toward an increased risk
associated with phosphorus intake in women (OR, 3.5; 0.8-
15.9; P for trend 0.08), but not in men (OR, 1.4; 0.4-4.7).
There was no significant interaction between calcium and
phosphorus intakes and the highest level of the calcium-
phosphorus ratio yielded an odds ratio of 1.3 in both men
and women (P>0.10).
Table H Relationship between intake of calcium, phosphorous and vitamin D and colorectal adenomasa, C6te d'Or, 1985-90
Quintiles P-valuefor
1 2 3 4 5 trend
Phosphorus Small n case/ctl 41/85 44/86 26/85 25/86 18/85
adenomas OR 1.0 1.1 0.7 0.7 0.5
95% CI (0.6-1.9) (0.4-1.3) (0.3-1.4) (0.2-1.2) 0.06
Large n case/ctl 49/41 57/44 38/26 34/25 30/18
adenomas OR 1.0 1.1 1.2 1.2 1.4
95% CI (0.6-2.0) (0.5-2.6) (0.5-2.7) (0.5-3.9) 0.56
Calcium Small n case/ctl 35/85 48/86 21/85 27/86 23/85
adenomas OR 1.0 1.5 0.7 1.0 0.9
95% CI (0.9-2.6) (0.4-1.4) (0.5-1.8) (0.4-1.7) 0.28
Large n case/ctl 46/35 58/48 40/21 35/27 29/23
adenomas OR 1.0 0.9 1.3 0.9 0.9
95% CI (0.5-1.6) (0.6-2.8) (0.5-1.9) (0.4-1.9) 0.85
Non-dairy Small n case/ctl 46/85 35/86 28/85 23/86 22/85
calcium adenomas OR 1.0 0.8 0.7 0.6 0.6
95% CI (0.5-1.4) (0.4-1.2) (0.3-1.1) (0.3-1.1) 0.04
Large n case/ctl 50/46 48/35 40/28 35/23 35/22
adenomas OR 1.0 1.3 1.3 1.4 1.5
95% CI (0.7-2.3) (0.7-2.5) (0.7-2.7) (0.7-2.9) 0.26
Dairy Small n case/ctl 28/85 43/86 35/85 25/86 23/85
calcium adenomas OR 1.0 1.6 1.4 1.1 1.0
95% CI (0.9-2.9) (0.8-2.5) (0.6-2.0) (0.5-2.0) 0.63
Large n case/ctl 39/28 53/43 57/35 32/25 27/23
adenomas OR 1.0 0.9 1.1 0.8 0.8
95% CI (0.5-1.6) (0.6-2.1) (0.4-1.7) (0.3-1.7) 0.59
Vitamin D Small n case/ctl 41/85 33/86 36/85 22/86 22/85
adenomas OR 1.0 0.9 1.0 0.6 0.7
95% CI (0.5-1.5) (0.5-1.7) (0.3-1.2) 0.4-1.3 0.14
Large n case/ctl 49/41 49/41 48/36 34/22 28/22
adenomas OR 1.0 1.3 1.1 1.2 1.0
95% CI (0.7-2.4) (0.6-2.0) (0.6-2.4) (0.5-2.1) 0.95
aSmall adenomas compared with polyp-free controls, large compared with small adenomas.Calcium, dairy products and colorectal tumours
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Dairy products and colorectal cancer (Table III)
No particular type of dairy product was associated with risk
of colorectal cancer, apart from an increased risk in men
drinking full-fat milk (OR 1.8; P=0.03), which was not
observed in women (OR 1.0; P=0.95).
Dairy products and colorectal adenomas (Table IV)
No particular type of dairy product was significantly
associated with the risk of small adenomas. As for large
adenoma patients, they consumed significantly less yoghurt
than small adenoma patients, with a global odds ratio for
men and women combined of 0.6 (0.4-1.1) for consumers of
less than half a yoghurt per day, and 0.5 (0.3-1.0) for
consumers of at least half a yoghurt per day, compared with
subjects who did not consume yoghurt (P for trend=0.03).
When controlling for alcohol intake, which has been found to
be the only nutrient significantly associated with the risk of
large adenomas (Boutron et al., 1995), the association
remained but was slightly reduced (OR category 3 vs no
consumption, 0.6; P for trend 0.08). The association was not
modified when controlling for fruit intake which was the only
other food associated with a reduced risk of large adenomas
(Boutron 1995). This inverse association with yoghurt intake
was slightly different in men and in women. In men, only the
highest level of intake was associated with a reduced risk,
whereas in women, the difference was between those who
consumed vs those who did not consume yoghurt. In
addition, consumption of full-fat milk was associated with
a moderately increased risk of large adenomas in men (OR
1.7; P=0.07) but not in women (OR 0.8; P=0.45).
Discussion
Our results do not support the hypothesis that calcium exerts
a protective effect against colorectal tumours. The only
exception, and then only in men, was a negative association
between low-fat calcium and large adenomas. We even
observed a small positive association between calcium intake
and risk ofcolorectal cancer. Vitamin D was inversely related
only to the risk of small adenomas in women. Intake of
yoghurt was inversely related to the risk of large adenomas.
Retrospective assessment ofdietary intake is one limitation
of case-control studies. We chose to study the adenoma-
carcinoma sequence stepwise in order to reduce the potential
impact of dietary changes over time. Changes in diet due to
the disease are another concern, but it is unlikely that this
bias would explain the failure to observe a protective effect of
dietary calcium. Our patients with adenomas had no reason
for having modified their diet, because adenomas are mostly
asymptomatic, and also because we had excluded subjects
with a previous history of adenomas. There is no reason why
patients with cancer should have increased their intake of
dairy products as a result of their disease. Prospective studies
are not submitted to the potential recall bias, and some also
failed to observe a protective effect of dietary calcium, and
have even found a positive association with cancer (Bostick et
al., 1993). The quality of retrospective dietary assessment is
another important determinant of the validity of such a
study. We performed a pilot study in order to test and adapt
available dietary history questionnaires and we validated our
questionnaire (Boutron et al., 1989). The way of comparing
the different groups of cases and controls is also debatable. In
accordance with Hill's hypothesis (Hill et al., 1978) of two
Table III Relationship between calcium or dairy products intake and colorectal cancer, C6te d'Or, 1985-90
Quintilesa P-valuefor
1 2 3 4 5 trend
Phosphorus n case/ctl 25/61 29/62 33/62 36/62 48/62
OR 1.0 1.2 1.3 1.5 1.9
95% CI (0.6-2.4) (0.6-2.7) (0.7-3.3) (0.8-4.6) 0.17
Calcium n case/ctl 25/61 34/62 34/62 27/62 51/62
OR 1.0 1.3 1.3 1.0 1.7
95% CI (0.7-2.5) (0.7-2.4) (0.5-1.9) (0.8-2.3) 0.33
Non-dairy n case/ctl 27/61 25/62 39/62 36/62 44/62
calcium OR 1.0 0.9 1.4 1.3 1.6
95% CI (0.5-1.8) (0.7-2.6) (0.7-2.5) (0.8-3.0) 0.11
Dairy n case/ctl 22/61 36/62 31/62 35/62 47/62
calcium OR 1.0 1.5 1.3 1.5 1.8
95% CI (0.8-2.9) (0.7-2.6) (0.8-2.8) (0.9-3.4) 0.17
Vitamin D n case/ctl 29/61 26/62 38/62 50/62 29/62
OR 1.0 0.8 1.2 1.5 0.8
95% CI (0.4-1.6) (0.6-2.2) (0.8-2.9) (0.4-1.6) 0.77
Milk (total) n case/ctl 27/62 50/62 25/62 33/61 36/62
OR 1.0 1.7 0.8 1.2 1.2
95% CI (0.9-3.2) (0.4-1.6) (0.6-2.2) (0.6-2.2) 0.66
Low fat n case/ctl 29/62 27/62 49/62 35/61 31/62
milk OR 1.0 1.0 1.6 1.2 1.0
95% CI (0.5-1.8) (0.9-2.8) (0.7-2.3) (0.5-1.9) 0.76
Cheese n case/ctl 32/62 32/62 37/62 42/61 28/62
OR 1.0 1.5 1.3 1.3 1.2
95% CI (0.8-2.7) (0.7-2.4) (0.7-2.4) (0.6-2.2) 0.89
Cottage n case/ctl 68/132 46/87 57/90
cheese OR 1.0 1.1 1.2
95% CI (0.7-1.7) (0.8-1.9) 0.39
Yoghurt 71/123 52/93 48/93
1.0 1.0 1.0
(0.7- 1.7) (0.6- 1.6) 0.93
aQuintiles for all foods except yoghurt and cottage cheese (three levels).steps before cancer itself, i.e. adenoma formation and
adenoma growth, we chose to compare our adenoma groups
stepwise. It should be emphasised that because the adenoma
and polyp-free groups were obtained from endoscopy lists
and thus represent a selected group of subjects, odds ratios
cannot be assumed to represent population relative risks.
They rather provide an estimation ofthe significance of a risk
factor in a selected population. Nevertheless, as adenomas
are mostly asymptomatic, and only a small sample of
adenoma-bearing subjects are diagnosed, comparing them
with our population controls would have introduced bias.
The debate about a possible protective effect of calcium
intake on colorectal cancer is relatively recent. The
epidemiological evidence relating colorectal cancer and
intakes of calcium, vitamin D or dairy products has recently
been summarised (Bostick et al., 1993). A protective effect of
calcium, not always statistically significant, was suggested in
five of nine case-control and in three of five cohort studies
(Garland et al., 1985; Stemmermann et al., 1990; Bostick et
al., 1993). In a later study in the Netherlands (Kampman et
al., 1994b), calcium was even positively, although not
significantly, associated with cancer risk, as in our own study.
The inconsistency of the effect of calcium on colorectal
cancer may be caused by the level of intake in the studied
communities. Most studies which observed a significant effect
were performed in the USA, where the mean consumption of
calcium is lower than in our population (Weaver, 1994). One
may hypothesise that only subjects with insufficient calcium
intake have a higher risk of colorectal tumours and that
doses above a certain level may not be beneficial. In an
animal experiment, the effect of bile acids on colonic cell
proliferation was enhanced by a calcium-depleted diet
Calcium, dairy products and colorectal tumours
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(0.1%), but a high daily calcium intake (1%) did not confer
any additional protection compared with the standard
calcium diet (0.5%) (Piard et al., 1994).
The mechanisms of a possible protective effect of calcium
have been mainly investigated through studies of colonic cell
proliferation in animals (Piard et al., 1994) and in high-risk
subjects (Lipkin and Newmark, 1985). Calcium supplements
decreased colonic cell hyperproliferation in subjects with a
personal history of colorectal tumours (O'Sullivan et al.,
1993). Calcium has been suggested as having a direct effect
on colonic cells, inducing terminal differentiation and growth
limitation (Buset et al., 1990). Its effect has also been related
to the binding of free bile acids (FBA) and fatty acids (FA)
to form insoluble soaps (Newmark et al., 1984). Such a
reaction depends on the colonic levels of calcium and
phosphorus and on the pH. We did not observe any
modulating effect of phosphorus on the relationship between
calcium and colorectal tumours, possible because in our study
population calcium and phosphorus intakes were highly
correlated (correlation coefficient above 0.8).
The absence of effect of dietary calcium on risk of
adenomas in our study is consistent with all other
epidemiological studies on adenomas (Kampman et al.,
1994a). This contrasts with the protective effect observed on
colonic cell proliferation, and raises questions about the
mechanisms of action of calcium in the adenoma-carcinoma
sequence. If the on-going intervention studies demonstrate a
protective effect of calcium supplements on colorectal
adenomas, this may lead to advising calcium supplements
rather than increasing dietary consumption of calcium.
Three case-control and two cohort studies considered the
effect of vitamin D, three suggested a protective effect,
Table IV Relationship between dairy products intake and colorectal adenomasa, C6te d'Or, 1985-90
Quintiles b P-valuefor
1 2 3 4 5 trend
Milk (total) Small n case/ctl 32/85 38/86 25/85 29/85 30/86
adenomas OR 1.0 1.3 0.8 0.9 1.1
95% CI (0.7-2.3) (0.4-1.6) (0.5-1.7) (0.6-1.9) 0.71
Large n case/ctl 41/32 44/38 34/25 49/29 40/30
adenomas OR 1.0 0.9 1.0 1.2 1.0
95% CI (0.5-1.7) (0.5-2.0) (0.6-2.4) (0.5-2.0) 0.60
Low-fat Small n case/ctl 36/85 37/86 22/85 28/85 31/86
milk adenomas OR 1.0 1.2 0.7 0.8 1.0
95% CI (0.7-21) (0.4-1.3) (0.5-1.5) (0.5-1.7) 0.53
Large n case/ctl 43/36 42/37 46/22 38/28 39/31
adenomas OR 1.0 0.9 1.7 1.1 1.1
95% CI (0.5-1.8) (0.9-3.5) (0.6-2.2) (0.5-2.1) 0.64
Cheese Small n case/ctl 29/85 50/86 20/85 26/85 29/86
adenomas OR 1.0 2.2** 1.2 1.2 1.2
95% CI (1.2-3.8) (0.6-2.2) (0.6-2.2) (0.6-2.4) 0.52
Large n case/ctl 36/29 52/50 44/20 43/26 33/29
adenomas OR 1.0 0.8 1.3 1.3 1.1
95% CI (0.4-1.6) (0.7-2.8) (0.6-2.6) (0.5-2.5) 0.33
Cottage Small n case/ctl 65/189 42/97 47/141
cheese adenomas OR 1.0 1.3 1.0
95% CI (0.8-2.1) (0.7-1.6) 0.79
Large n case/ctl 78/65 66/42 64/47
adenomas OR 1.0 1.3 1.1
95% CI (0.8-2.2) (0.7-1.8) 0.66
Yoghurt Small n case/ctl 37/126 72/148 45/153
adenomas OR 1.0 2.0* 1.3
95% CI (1.3-3.3) (0.8-2.2) 0.43
Large n case/ctl 75/37 89/72 44/45
adenomas OR 1.0 0.6 0.5*
95% CI (0.4-1.1) (0.3-0.9) 0.03
aSmall adenomas compared with polyp-free controls, large compared with small adenomas. bQuintiles for all foods except yoghurt and cottage
cheese (three levels). *P<0.05; **P<0.01.m it~~~~~~~~~C Bournata
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sigmncant m two (Bostick et al., 1993). We observed an
inverse association between vitamin D intake and risk of
small adenomas only in women. This may be owing to low
consumption levels in our population, as dairy products were
not supplemented with vitamin D in France at the time ofthe
study.
Eleven case-control and two cohort studies have
investigated the effect of dairy products (Bostick et al.,
1993). Nine suggested an inverse relationship which was
significant in four. Some dairy products may have a specific
effect on colorectal carcinogenesis, independently of their
calcium content. It might be suggested that in countries
where milk consumption is high, a protective effect of milk
itself has been misleadingly attributed to calcium. In lactose
malabsorbers, the non-absorbed lactose is fermented in the
colon. Fermentation of the closely related lactulose has been
demonstrated to be an asset against colorectal carcinogenesis
(Nagengast et al., 1988). It decreases intestinal pH, thus
reducing the transformation of primary into secondary bile
acids. Only populations with a relatively high proportion of
lactase-persistent subjects have a tradition of adults drinking
large quantities of milk (Sahi, 1994). This might explain in
part why dairy products are more often found protective in
Anglo-Saxon or Nordic communities than in Latin commu-
nities.
Fermented dairy products have been proposed as
protective against colorectal carcinogenesis, but the defini-
tion of these products differs from one study to another. We
decided to study each type separately, as their bacterial
content is different. Yoghurt spifically displayed an inverse
relationship with risk of large adenomas, suggesting that
consumers of at least half a yoghurt per day might be at
lesser risk. If this is confirmed, consumption of three
yoghurts per week would be easily practicable as a
prevention measure. A correlation study in Denmark and
Finland suggested a protective role of fermented milk and
lactobacilli against colorectal cancer (Report from the IARC
Intestinal Microecology Group, 1977), with an incidence rate
significantly lower in Finns, who consume larger quantities of
fermented dairy products and have a higher rate of
lactobacilli in their stools, than Danes. Few epidemiological
studies have addressed a possible association between
fermented dairy products and colorectal tumours. An inverse
association was observed in population-based case-control
studies of colon cancer, with yoghurt (Peters et al., 1992) or
fermented milk consumption (Young and Wolf, 1988). In
contrast, a recent study in the Netherlands (Kampmann et
al., 1994b) observed no protective effect of fermented dairy
products or of yoghurt. A small non-significant inverse
relationship between adenomas and fermented dairy products
has been observed (Kampmann et al., 1994a). The
mechanisms by which fermented dairy products might
inhibit colon carcinogenesis are speculative. Most of the
lactose contained in fermented dairy products is absorbed in
the small intestine, even in lactase-deficient subjects (Marteau
et al., 1990). Lactic acid bacteria are more likely to be the
active component (Rafter, 1995). Some species have been
demonstrated to bind carcinogens, decrease the concentration
of pro-carcinogen activating enzymes, produce anti-muta-
genic compounds or modulate the immune response (Pool-
Zobel et al., 1993; Marteau and Rambaud, 1993; Rafter,
1995). However, these properties are strain-specific, and
bacterial quantities in experimental studies are usually far
higher than those consumed by humans. L. bulgaricus and S.
thermophius have been less studied with regard to colon
carcinogenesis than other bacteria such as L. acidophilus or
L. casei. They are not of human origin and they survive
poorly their transit through the stomach and the intestine
(Marteau and Rambaud, 1993), but they have exhibited some
anti-carcinogenic properties in vitro (Pool-Zobel et al., 1993).
In conclusion, this study failed to support a protective
effect ofdietary calcium on colorectal carcinogenesis, which is
in agreement with findings in other Latin countries (Benito et
al., 1991). This should prompt further research on the specific
effect of certain dairy products. Preventive advice should
encourage taling calcium supplements rather than increasng
dietary intake of calcium in particular in patients who may
otherwise benefit from calcium supplements, such as post-
menopausal women for preventing osteoporosis.
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